Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro

BACKGROUND: We examined the association of tumor-derived hepatocyte growth factor (HGF) with the clinicopathological features of gliomas and investigated the effect of HGF inhibition on the biological behavior of tumor cells in vitro in order to determine whether HGF is a valuable prognostic predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, You-feng, Wang, Xiao-bing, Tian, Xiao-ying, Li, Yang, Li, Bin, Huang, Quan, Zhang, Meng, Li, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447698/
https://www.ncbi.nlm.nih.gov/pubmed/22741575
http://dx.doi.org/10.1186/1477-7819-10-128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447698/
https://www.ncbi.nlm.nih.gov/pubmed/22741575
http://dx.doi.org/10.1186/1477-7819-10-128

Ejemplares similares